• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type

tetano

Editor, Senior Moderator
Vaccine. 2016 Jun 17. pii: S0264-410X(16)30400-5. doi: 10.1016/j.vaccine.2016.06.001. [Epub ahead of print]
[h=1]Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type.[/h] Sandbulte MR[SUP]1[/SUP], Gauger PC[SUP]2[/SUP], Kitikoon P[SUP]3[/SUP], Chen H[SUP]4[/SUP], Perez DR[SUP]4[/SUP], Roth JA[SUP]1[/SUP], Vincent AL[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The neuraminidase (NA) protein of influenza A viruses (IAV) has important functional roles in the viral replication cycle. Antibodies specific to NA can reduce viral replication and limit disease severity, but are not routinely measured. We analyzed NA inhibiting (NI) antibody titers in serum and respiratory specimens of pigs vaccinated with intramuscular whole-inactivated virus (WIV), intranasal live-attenuated influenza virus (LAIV), and intranasal wild type (WT) IAV. NI titers were also analyzed in sera from an investigation of piglet vaccination in the presence of passive maternally-derived antibodies. Test antigens contained genetically divergent swine-lineage NA genes homologous or heterologous to the vaccines with mismatched hemagglutinin genes (HA). Na?ve piglets responded to WIV and LAIV vaccines and WT infection with strong homologous serum NI titers. Cross-reactivity to heterologous NAs depended on the degree of genetic divergence between the NA genes. Bronchoalveolar lavage specimens of LAIV and WT-immunized groups also had significant NI titers against the homologous antigen whereas the WIV group did not. Piglets of vaccinated sows received high levels of passive NI antibody, but their NI responses to homologous LAIV vaccination were impeded. These data demonstrate the utility of the enzyme-linked lectin assay for efficient NI antibody titration of serum as well as respiratory tract secretions. Swine IAV vaccines that induce robust NI responses are likely to provide broader protection against the diverse and rapidly evolving IAV strains that circulate in pig populations. Mucosal antibodies to NA may be one of the protective immune mechanisms induced by LAIV vaccines.
Published by Elsevier Ltd.


[h=4]KEYWORDS:[/h] Influenza A virus; Live attenuated influenza virus; Maternally derived antibodies; Mucosal immunity; Neuraminidase inhibiting antibodies; Whole inactivated virus

PMID: 27325350 [PubMed - as supplied by publisher]
 
Back
Top Bottom